Top

BMC Urology

Published in:

01-12-2020 | Nephrostomy | Case report

A case report of primary upper urinary tract signet-ring cell carcinoma and literature review

Authors: Zhaohua Ye, Qiwu Mi, Daosheng Luo, Zhixiong Li, Jiexin Luo

Published in: BMC Urology | Issue 1/2020

Abstract

Background

Upper tract urothelial carcinoma with pure non-urothelial histology is an exception but variants are present in ~ 25% of cases. Primary upper urinary tract signet -ring cell carcinoma is extremely rare.

Case presentation

We report the case of a 65-year-old male diagnosed primary upper urinary tract signet-ring cell carcinoma while underwent percutaneous nephrolithotomy. Radical nephroureterectomy and adjuvant chemotherapy were performed sequentially. The patient is now recovering well with a regular follow-up for more than 1 year.

Conclusions

The upper urinary tract malignancy often appears as a high grade, high stage tumor and has a uniformly poor prognosis, but a timely multimodal management can bring a good outcome.

Rink M, Robinson BD, Green DA, et al. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol. 2012;188(2):398–404. https://doi.org/10.1016/j.juro.2012.04.009.CrossRefPubMed

Masson-Lecomte A, Colin P, Bozzini G, et al. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2014;32(2):531–7. https://doi.org/10.1007/s00345-013-1141-0.CrossRefPubMed

Olgac S, Mazumdar M, Dalbagni G. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol. 2004;28(12):1545–52.CrossRef

Perez-Montiel D, Wakely PE, Hes O, et al. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol. 2006;19:494–503. https://doi.org/10.1038/modpathol.3800559.CrossRefPubMed

Delahunt B, Nacey JN, Meffan PJ. Signet ring cell adenocarcinoma of the ureter [J]. Brit J Urol. 1991;68(5):555–6.CrossRef

Roupret M, Babjuk M, Comperat E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73(1):111–22.CrossRef

Siggel RL, Miller KD. Cancer statitics, 2016. CA Cancer J Clin. 2016;66:7–30.CrossRef

Siggel RL, Miller KD. Cancer statitics, 2015. CA Cancer J Clin. 2015;65:5–29.CrossRef

Munoz JJ, et al. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164:1523.CrossRef

10.

Shariat SF, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29:481.CrossRef

11.

Lughezzani G, Sun M, Perrotte P, et al. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the surveillance, epidemiology, and end results database. Urology. 2010;75:321–7. https://doi.org/10.1016/j.urology.2009.09.048.CrossRefPubMed

12.

Grignon DJ, Ro JY, Ayala AG, Johnson DE. Signet-ring cell carcinoma of the urinary bladder. Am J Pathol. 1955;31:223–31.

13.

Ekfors TO. Primary signet-ring cell carcinoma of the ureter. A case report. APMIS. 1988;96:471–4.CrossRef

14.

Brawer MK, Waisman J. Papillary adenocarcinoma of ureter. Urology. 1982;19:205–9.CrossRef

15.

Nocks BN, Heney NM, Daly JJ. Primary adenocarcinoma of the urinary bladder. Urology. 1983;21:26–9.CrossRef

16.

Thomas DG, Ward AM, Williams JL. A study of 52 cases of adenocarcinoma of the bladder. Br J Urol. 1971;43:4–15.CrossRef

17.

Ward AM. Glandular neoplasia within the urinary tract. The aetiology of adenocarcinoma of the urothelium with a review of the literature. I. Introduction: the origin of glandular epithelium in the renal pelvis, ureter and bladder. Virchows Arch A Pathol Pathol Anat. 1971;352:296–311.CrossRef

18.

Braun EV, Majid A, Fayemi A, Beaugard E. Primary signet-ring cell carcinoma of the urinary bladder: Review of the literature and report of a case. Cancer. 1981;47:1430–5.CrossRef

19.

Choi H, Lamb S, Pintar K, Jacobs SC. Primary signet-ring cell carcinoma of the urinary bladder. Cancer. 1984;53:1985–90.CrossRef

20.

DeTure FA, Dein R, Hackett RL, Drylie DM. Primary signet-ring cell carcinoma of bladder exemplifying vesical epithelial multipotentiality. Urology. 1975;6:240–4.CrossRef

21.

Abbas M, Kramer MW, Spieker T, Herrman TR, Merseburger AS, Müller KM, Kuczyk MA, Becker JU, Kreipe HH. Primary mucinous adenocarcinoma of the renal pelvis with carcinoma in situ in the ureter. J Egypt Natl Canc Inst. 2014;26:51–4.CrossRef

22.

Fojecki G, Magnusson A, Traxer O, et al. Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma. World J Urol. 2019;37:2271–8. https://doi.org/10.1007/s00345-019-02732-8.CrossRefPubMedPubMedCentral

23.

Skolarikos A, et al. Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology. 2003;61(6):1146–50.CrossRef

24.

Kobayashi Y, Saika T, Miyaji Y, et al. Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. World J Urol. 2012;30:271–5. https://doi.org/10.1007/s00345-011-0731-y.CrossRefPubMed

25.

Tanaka N, Kikuchi E, Kanao K, et al. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study. Urol Oncol. 2014;32:48.e19–26. https://doi.org/10.1016/j.urolonc.2013.07.003.CrossRef

26.

Margolin EJ, Matulay JT, Li G, et al. Discordance between Ureteroscopic biopsy and final pathology for upper tract Urothelial carcinoma. J Urol. 2018;199:1440–5. https://doi.org/10.1016/j.juro.2018.02.002.CrossRefPubMed

27.

STEARNS DB, FARMER DA. Ureteral metastasis secondary to gastric carcinoma: case report. J Urol. 1958;80:214–7.CrossRef

28.

Hes O, Curík R, Mainer K. Urothelial signet-ring cell carcinoma of the renal pelvis with collagenous spherulosis: a case report. Int J Surg Pathol. 2005;13:375–8.CrossRef

29.

Singh J, Zherebitskiy V, Grynspan D, et al. Metastatic signet ring cell adenocarcinoma of the bladder. Can Urol Assoc J. 2013;6:E15–9.CrossRef

30.

Lendorf ME,Dohn LH,Á Dunga B,et al. An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case. Scand J Urol 2018;52:87–93.DOI:https://doi.org/10.1080/21681805.2017.1418020.

31.

Suh N, Yang XJ, Tretiakova MS, Humphrey PA, Wang HL. Value of CDX2, villin, and alpha-methylacyl coenzyme a racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol. 2005;18:1217–22.CrossRef

32.

Dong MJ, Lin XT, Zhao J, et al. Malignant tumor with false negative 18F-FDG PET image. Zhonghua Zhong Liu Za Zhi. 2006;28:713–7.PubMed

33.

JUDD RL. Melanoma of the ureter: a case report. J Urol. 1962;87:805–7.CrossRef

34.

Birtle AJ, Chester JD, Jones RJ, et al. Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC). J Clin Oncol. 2018;36(6_suppl):407.CrossRef

35.

Cobo-Dols M, Alcaide J, Gutiérrez V, et al. Primary signet-ring cell adenocarcinoma of the urinary bladder: a case report. Oncología (Barc). 2006;29:177–80.

36.

El Ammari JE, Ahsaini M, Riyach O, et al. Primary signet-ring cell carcinoma of the urinary bladder successfully managed with cisplatin and gemcitabine: a case report. J Med Case Rep. 2013;7:37. https://doi.org/10.1186/1752-1947-7-37.CrossRefPubMedPubMedCentral

Title: A case report of primary upper urinary tract signet-ring cell carcinoma and literature review
Authors: Zhaohua Ye
Qiwu Mi
Daosheng Luo
Zhixiong Li
Jiexin Luo
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Nephrostomy
Nephrostomy
Urothelial Cancer
Urothelial Cancer
Published in: BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI: https://doi.org/10.1186/s12894-020-00645-y

At a glance: The STEP trials

Springer Medicine

A case report of primary upper urinary tract signet-ring cell carcinoma and literature review

Abstract

Background

Case presentation

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer

Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome

The risk factors related to the severity of pain in patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

MicroRNA-219c-5p regulates bladder fibrosis by targeting FN1

Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically

Incidental para-ureteral aggressive angiomyxoma: a rare case report and literature review